European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. Internet] [link].

Food and Drug Administration 71

Food and Drug Administration Pharmaceutical products FDA Pharmacology 71

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Management 72

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 72

European Pharmaceutical Review

JANUARY 9, 2024

Adding these developments with the addition of connected IoT devices, supply chain restructuring and consideration for our code of ethics will give us a glimpse at how pharmaceutical production will look in future. Internet] US Food and Drug Administration (FDA). Tuijin Jishu / Propuls. 2023; 44(3):1384-1392.

Pharmaceutical manufacturing 121

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 121

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. How can these issues be addressed?

Pharmaceutical 92

Pharmaceutical Food and Drug Administration Transportation Manufacturing 92

European Pharmaceutical Review

MARCH 12, 2024

Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. What is the main recommendation you would make to the pharmaceutical/life science industry to ensure a strong data governance framework?

Government 84

Government Pharma Ethics Training 84

Pharmaceutical Technology

MARCH 22, 2023

Various uses soon became apparent including those for supply chain management, anti-counterfeiting, and to improve patient safety. The US Food and Drug Administration (FDA) has provided guidance for the use of RFID in the drug supply chain and to standardise the data format. Cloud-based registries and RFID – a value-add?

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma FDA 105

European Pharmaceutical Review

DECEMBER 27, 2023

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks.

Manufacturing 80

Manufacturing Food and Drug Administration Patients Pharma 80

Cadensee

JULY 20, 2021

Uri Goren is the head of digital engagement and capabilities at Teva Pharmaceuticals, and just recently became a member of the National Advisory Board for digital health for the Israel Ministry of Health. 02:25 Uri Goren talks about his road to become a trailblazer and advocate for patient-centric healthcare. Show Notes.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Pharmaceutical Technology

NOVEMBER 30, 2022

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. The evolution of CCIT. Many test methods have thus been developed.

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical products Manufacturing Pharmaceutical 52

Pharmaceutical Technology

APRIL 26, 2023

The packaging should also offer increased ergonomics to patients and medical personnel, such as ease of extraction of the product from the packaging and directing the user with specific marking and sequence to identify and use multi-component sets.

Manufacturing 52

Manufacturing Medical Food and Drug Administration Pharmaceutical 52